公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2006 | Weekly Cisplatin Plus Infusional High-Dose 5-Fluorouracil and Leucovorin (P-HDFL) for Metastatic Urothelial Carcinoma --- An Effective Regimen with Low Toxicity | Lin, Chia-Chi; Hsu, Chih-Hung; Huang, Chao-Yuan; Cheng, Ann-Lii; Chen, Jun; Vogelzang, Nicholas J.; Pu, Yeong-Shiau | Cancer | | | |
2007 | Weekly paclitaxel and high-dose 5-Fluorouracil plus leucovorin (T-HDFL) in hormone-refractory prostate cancer: in Vitro combined effects and phase II trial | Lin, Chia-Chi; Hsu, Chih-Hung; Hour, Tzyh-Chyuan; Cheng, Ann-Lii; Huang, Chao-Yuan; Huang, Kuo-How; Chen, Jun; Pu, Yeong-Shiau | UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | | | |
2013 | WNT/beta-catenin signaling inhibitors improve the anti-proliferative effect of sorafenib against hepatocellular carcinoma (HCC) cells. | Lin, Hsiao-Hui; Feng, Wen-Chi; Lu, Li-Chun; Shao, Yu-Yun; Cheng, Ann-Lii; Hsu, Chih-Hung; 鄭安理 | Cancer Res. | | | |
2013 | WNT/beta-catenin signaling inhibitors improve the anti-proliferative effect of sorafenib against hepatocellular carcinoma (HCC) cells. | Lin, Hsiao-Hui; Feng, Wen-Chi; Lu, Li-Chun; Shao, Yu-Yun; Cheng, Ann-Lii; Hsu, Chih-Hung | Cancer Res. | | | |
2009 | 不同方法之震譜相符強地動歷時對結構地震需求之變異性探討 | 許志鴻; Hsu, Chih-Hung | | | | |
2015 | 投資人參與初次上市(櫃)詢價圈購影響因素之研究 | 許志宏; Hsu, Chih-Hung | | | | |
2006 | 稅負誘發之股權結構移轉與股利偏好探討 | 許志鴻; Hsu, Chih-Hung | | | | |